UP-TO-DATE, RESEARCH BASED INFORMATION ABOUT PSYCHEDELICS.
A brief review on the potential of psychedelics for treating Alzheimer’s Disease and related depression
Psychedelic drugs target AD-related psychological pathology and symptoms such as depression. Using microdosing, psychedelic drugs may prove to help combat this devastating disease by eliciting psychiatric benefits via acting through various mechanisms of action such as serotonin and dopamine pathways.
The potential for psychedelics to improve coping skills and resilience in persons with newly diagnosed mild cognitive impairment or early Alzheimer’s disease
We discuss pre-clinical evidence suggesting that these benefits may also extend to Mild Cognitive Impairment and mild Alzheimer’s disease
